Trump said his most favored nation plan would lower drug prices in the U.S. “almost immediately by 30% to 80%," But without ...

Inappropriate polypharmacy—the excessive or unnecessary use of multiple medications—is a major driver of emergency hospital ...

As the last nameplate standing from the legacy Bed Bath & Beyond empire, this brand occupies an ill-defined niche in the ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

Employees enrolled in HDHPs are often the most exposed to price volatility, making pharmacy strategy a critical lever in any ...

These three tech giants in Cuban's portfolio are still long-term plays despite incredible gains in the past several years.

As federal lawmakers continue to debate major reforms to Medicaid spending, entrepreneur Mark Cuban is proposing what he believes is “the best way to reduce the cost of Medicaid.” In a June 26 post on ...

For instance, Wan et al found that pembrolizumab plus standard chemotherapy for NSCLC was not cost-effective from the perspectives of US and Chinese payers. 16 Similar conclusions were drawn for other ...

Once dismissed as unreliable, govt-supplied generic medicines are gaining traction — thanks to soaring medical costs, ...

The pharmacists have warned that without intervention, more pharmacies will close and upstate New York risks pharmacy deserts ...

Billionaire entrepreneur and Cost Plus Drugs founder Mark Cuban believes that these two changes could dramatically improve ...

As with many chronic and often deadly diseases, an ounce of prevention can be worth a ton of cure. It's a breakthrough drug for sure for those wanting to avoid HIV AIDS, but the price is eye popping.